Chaperone and Age-Related Macular Degeneration Model
About the Research Project
Program
Award Type
Standard
Award Amount
$100,000
Active Dates
April 01, 2007 - December 31, 2009
Grant ID
M2007037
Goals
These investigators have established a genetically distinct mouse lineage that develops many features similar to AMD. By studying these mice, the investigators hope to learn more about the causes of AMD and potentially suggest new therapies.
Summary
Age-related macular degeneration (AMD) is the leading cause of blindness among the elderly in the USA and developed countries. Currently, there is no treatment for the disease. AMD results from damage to the retina, a neuronal tissue in the eye that is responsible for vision. We have established a mouse strain that shows many AMD features. We hypothesize that these features may result from the accumulation of certain toxic proteins in retinal cells. We propose to study this mouse model and identify the specific toxic proteins. We plan to find therapies to eliminate these toxic proteins and treat AMD.
Related Grants
Macular Degeneration Research
Development of an Oral Treatment for Dry AMD Using Everyday Anti-Inflammatory Drugs
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Marco Bassetto, PhD
Current Organization
University of California, Irvine
Development of an Oral Treatment for Dry AMD Using Everyday Anti-Inflammatory Drugs
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Marco Bassetto, PhD
Current Organization
University of California, Irvine
Macular Degeneration Research
Developing a New Treatment for Wet AMD: Targeted Removal of a Disease-Causing Protein
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Celia Bisbach, PhD
Current Organization
University of Wisconsin-Madison
Developing a New Treatment for Wet AMD: Targeted Removal of a Disease-Causing Protein
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Celia Bisbach, PhD
Current Organization
University of Wisconsin-Madison
Macular Degeneration Research
A Novel Implantable Device to Treat Wet Macular Degeneration
Active Dates
July 01, 2025 - June 30, 2028
Principal Investigator
Charles DeBoer, MD, PhD
Current Organization
Stanford University
A Novel Implantable Device to Treat Wet Macular Degeneration
Active Dates
July 01, 2025 - June 30, 2028
Principal Investigator
Charles DeBoer, MD, PhD
Current Organization
Stanford University